Literature DB >> 25711766

Response to: comment on "Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections".

Karen D Wright1, Clinton F Stewart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25711766      PMCID： PMC4401467          DOI： 10.1007/s00280-015-2699-6

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  2 in total

1.  Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections.

Authors:  Karen D Wright; John C Panetta; Arzu Onar-Thomas; Wilburn E Reddick; Zoltan Patay; Ibrahim Qaddoumi; Alberto Broniscer; Giles Robinson; Frederick A Boop; Paul Klimo; Deborah Ward; Amar Gajjar; Clinton F Stewart
Journal:  Cancer Chemother Pharmacol       Date:  2014-10-24       Impact factor: 3.333

Review 2.  Defining the appropriate dosage of folinic acid after high-dose methotrexate for childhood acute lymphatic leukemia that will prevent neurotoxicity without rescuing malignant cells in the central nervous system.

Authors:  Ian J Cohen
Journal:  J Pediatr Hematol Oncol       Date:  2004-03       Impact factor: 1.289
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.